Addleshaw Goddard advises Aleos Capital on the launch of its first investment vehicle

Addleshaw Goddard has advised Aleos Capital on the launch of its new fund, Aleos Fund I, which has a target size of between €150 million and €200 million

This new vehicle will seek to invest in companies in the biosciences sector, with a specific focus on opportunities related to health and wellness, sustainable nutrition, climate, and the environment. To this end, it plans to invest in companies with significant growth potential, focusing on Spain and Portugal, with the possibility of expanding its reach to southern Europe and Latin America.

Recently founded, Aleos Capital is a Spanish collective investment institution manager made up of experts in the private equity and healthcare markets.

The firm team advising Aleos Capital was led by Funds partner Isabel Rodríguez, with the collaboration of senior associate Enrique Torné and associate Nemesio Fernández.